Valganciclovir Impurity
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | ACTIONS |
|---|---|---|---|---|
|
(2-amino-9-(hydroxyl methyl)-1,9-dihydro-6H-purin-6-one) R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-33500 | ---- | |
|
(S,S)-Iso Valganciclovir Hydrochloride R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-T-93454 | 1401562-13-7 | |
|
2-((2-amino-6-oxo-l,6- dihydro-9H-purin-9-yl) methoxy)-3- hy... R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-37140 | Not Available | |
|
|
Impurity | CS-O-36117 | 960582-59-6 | |
|
|
Impurity | CS-T-62681 | 1393911-57-3 | |
|
|
Impurity | CS-O-34077 | Not Available | |
|
|
Impurity | CS-O-16462 | 130914-71-5 | |
|
Mixture of (S,R)-Iso Valganciclovir and (R,R)-Iso Valgancicl... R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-60317 | ---- | |
|
Mono Des valine valganciclovir Dimer R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-56610 | ---- | |
|
|
Impurity | CS-EO-03930 | 1401661-95-7 (Freebase) | |
|
|
Impurity | CS-O-20040 | 1401562-16-0 | |
|
N-Methyl-L-valine 2-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-y... R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-35213 | 1401661-95-7 | |
|
Valganciclovir dimer (stereoisomer B) R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-EO-00751 | Not Available | |
|
Valganciclovir D-VAline N-(D-Valyl) Impurity R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-34075 | ---- | |
|
Valganciclovir EP Impurity D (TFA salt) R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-EO-03929 | 1219792-42-3 (Freebase) | |
|
Valganciclovir EP Impurity F (TFA salt) R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-EO-03931 | 130914-71-5 (Freebase) | |
|
|
Impurity | CS-O-59869 | ---- | |
|
|
Impurity | CS-O-59870 | ---- | |
|
|
Impurity | CS-ED-39871 | 119089-68-8 | |
|
|
Impurity | CS-O-58943 | ---- | |
|
|
Impurity | CS-O-44879 | Not Available | |
|
Valganciclovir Homolog(component G as per USP) R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-16587 | 1356932-88-1 | |
|
|
Impurity | CS-T-32946 | 1356353-76-8 | |
|
|
Impurity | CS-P-08740 | 130914-77-1 | |
|
Valganciclovir Impurity Q Hydrochloride R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-50603 | Not Available | |
|
Valganciclovir N3,N3’-Methylene Dimer R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-T-87793 | 1401661-96-8 | |
|
Valganciclovir N-Valyl Hydrochloride R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-O-50602 | 897937-73-4(Freebase) | |
|
|
Impurity | CS-O-16427 | 897937-73-4 | |
|
Valganciclovir N-Valyl Impurity (TFA salt) R&D Available for Back Order. For exact timeline please enquire |
Impurity | CS-EO-03932 | 897937-73-4 (Freebase) | |
|
|
Impurity | CS-O-34045 | 1219792-42-3 |
![Structure - N-Methyl-L-valine 2-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl Ester](https://structures.clearsynth.com/CS-O-35213.png)
